RDZN 10-K & 10-Q changes, risk factors and insider trading
Roadzen Inc. (also RDZNW) · Nasdaq · Insurance Agents, Brokers & Service · CIK 1868640 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “We do not hold a controlling equity interest in our Chinese subsidiary and rely on contractual and governance arrangements for consolidation, which may be less effective than direct ownership and may be challenged under PRC law.”
New heading “Changes in PRC laws, regulations, or government policies, or actions by PRC regulatory authorities, could materially affect Daokang’s operations and our ability to consolidate Daokang’s financial results.”
New heading “The Holding Foreign Companies Accountable Act and related developments could result in our securities being prohibited from trading in the United States if the Public Company Accounting Oversight Board is unable to inspect our auditors.”
New heading “Restrictions on the movement of cash into and out of the PRC may limit our ability to use Daokang’s cash flows to fund our operations or meet our obligations.”
New heading “The accounting for our consolidation of Daokang involves significant judgment and estimates, and adjustments during the measurement period or in future periods could materially affect our reported results.”
Largest changes
“The Holding Foreign Companies Accountable Act, as amended (the “HFCAA”), and related rules adopted by the U.S. Securities and Exchange Commission and the Public Company Accounting Oversight Board (the “PCAOB”) provide that if the PCAOB is unable to inspect or investigate completely an auditor that has issued an audit report for a U.S.-listed issuer for two consecutive years, the issuer’s securities will be prohibited from trading on a U.S. national securities exchange or in the over-the-counter market. …”see in full comparison
“Changes in PRC laws, regulations, or government policies, or actions by PRC regulatory authorities, could materially affect Daokang’s operations and our ability to consolidate Daokang’s financial results.”see in full comparison
“The accounting for our consolidation of Daokang, including the determination that we are the primary beneficiary of Daokang for accounting purposes, the remeasurement of our previously held equity interest, the recognition and measurement of identifiable assets acquired and liabilities assumed, and the recognition of any goodwill or bargain purchase gain, involves the application of significant judgment and the use of estimates regarding fair value. The initial accounting may be recorded on a provisional basis and is subject to adjustment during the measurement period. …”see in full comparison
“The PRC government imposes controls on the convertibility of the Renminbi into foreign currencies and the remittance of currency out of the PRC. Daokang’s revenue is generated in Renminbi, and Daokang is subject to PRC laws and regulations governing dividend distributions, statutory reserve requirements, foreign exchange administration, and withholding tax on payments to non-PRC affiliates. …”see in full comparison
“The PRC government has broad authority to regulate companies operating in the PRC, including in areas relating to data, cybersecurity, foreign investment, anti-monopoly review, and the structure of overseas-listed issuers with PRC operations. …”see in full comparison
“The Holding Foreign Companies Accountable Act and related developments could result in our securities being prohibited from trading in the United States if the Public Company Accounting Oversight Board is unable to inspect our auditors.”see in full comparison
Full comparison: every changed paragraph (27)
We
have incurred net losses of $72.9 million$23.6 and $99.7$72.9 million for our fiscal years ended March 31, 20252026 and 2024,2025, respectively. As a
result, we
had an accumulated deficit of $224.3 million$248.6 and $151.6$224.3 million as of March 31, 20252026 and 2024,2025, respectively. We
anticipate that our operating
expenses will increase substantially in the foreseeable future as we continue to scale operations,
broaden our customer base, expand
our sales and marketing activities, including expanding our sales team, hire additional employees,
and continue to develop our technology.
In addition to the expected costs to grow our business, we also expect to incur significant
additional legal, accounting, and other expenses
as we transitionoperate to beingas a public company. These efforts may prove more expensive
than we currently anticipate, and we may not succeed in increasing
our revenue sufficiently, or at all, to offset these higher
expenses. Revenue growth may slow, or revenue may decline, for several possible
reasons, including slowing demand for our services
or increasing competition. Any failure to increase our revenue sufficiently to keep
pace with our investments and other expenses
could prevent us from achieving or increasing profitability or positive cash flow on a consistent
basis.
Our
revenue is dependent on clients in the automotive insurance industry, OEMs and automotive fleets, and historically a relatively small
number of clients have accounted for a significant portion of our revenue. For the year ended March 31, 2025,2026, we had three3 customers that
individually represented approximately 14%,13.0%, 13%10.0% and 10%8.0% of our total revenue. During this same period, revenues from 10 customers
collectively collectively
accounted for approximately 67%56.0% of our total revenue.
RecentFCA
FCA regulations and guidelines may have an adverse impact on our business and operations.
The
FCA has the authority to suspend the sale of any insurance product sold within the U.K. and for which it has oversight if it does not
not believe a firm or a product is protecting the interests of U.K. consumers. EffectiveFor example, in February 2024, the FCA paused all sales of
the Guaranteed Asset Protection (“GAP”) product, a key contributor to our operations in the U.K., directing all insurers,
insurers, including our insurance partner, to temporarily cease selling the GAP product. The regulator mandated insurers to make a resubmission,
resubmission, or new GAP proposal, outlining product features, coverages and pricing for approval by the FCA before sales of the GAP
product could
be resumed. Although our insurance partner, which is obligated to adhere to FCA guidelines, received approval to sell
GAP products, the
resubmission and approval process had a significant impact on our revenue, financial performance, and overall
profitability.
Global
events such as the imposition of various trade tariffs by the U.S. and China, the COVID-19 pandemic, the Russia-Ukraine andRussia-Ukraine, Israel-Hamas
and U.S.-Iran conflicts have created and may continue to create economic uncertainty, including inflationary pressures, in regions in
which we have
significant operations. These conditions may make it difficult for our customers and us to forecast and plan future business
activities activities
accurately, and they could cause our customers to reevaluate their decision to purchase our products, which could delay and
lengthen lengthen
our sales cycles or result in cancellations of planned purchases. Moreover, during challenging economic times, our customers
may be unable
to timely access sufficient credit, which could impair their ability to make timely payments to us. If that were to occur,
we may not
receive amounts owed to us and may be required to record an allowance for doubtful accounts, which would adversely affect
our financial
results. A substantial downturn in the insurance industry may cause firms to react to worsening conditions by reducing
their capital
expenditures, reducing their spending on information technology, delaying, or canceling information technology projects,
or seeking to
lower their costs by renegotiating vendor contracts. Negative or worsening conditions in the general economy in the U.S.,
the U.K., E.U.
E.U., China and India, including conditions resulting from financial and credit market fluctuations, could decrease corporate
spending on enterprise
software in general, and in the insurance industry specifically, and negatively affect the rate of growth of our
business.
We
expect to continue to derive most of our revenue from brokerage services and AI services we provide to the automotive industry, automotive
insurance industry and supporting economy, including the automotive collision and OEM industries. Given the concentration of our business
activities in this industry, we will be particularly exposed to certain economic downturns affecting the automotive and insurance industries.
Global market and economic conditions, as well as those in the U.S., the U.K., E.U.E.U., China and India, have been, and continue to be,
disrupted disrupted
and volatile. General business and economic conditions that could affect us and our customers include fluctuations in economic
growth, growth,
debt and equity capital markets, liquidity of the global financial markets, the availability and cost of credit, investor and
consumer consumer
confidence, and the strength of the economies in which our customers operate. A poor economic environment could result in significant
decreases in demand for our solutions, including the delay or cancellation of current or anticipated projects, or could present difficulties
in collecting accounts receivable from our customers due to their deteriorating financial condition. Our existing customers may be acquired
by or merged into other entities that use our competitors’ products, or they may decide to terminate their relationships with us
for other reasons. As a result, our sales could decline if an existing customer is merged with or acquired by another company that has
a poor economic outlook or is closed.
Roadzen
works with a limited number of carriers in the U.S., India, China, the U.K. and E.U. for its automobile insurance products, and there
is a risk
that if one or more of the carriers becomes impaired or terminates its relationship with Roadzen that Roadzen’s revenues
and profitability
may be adversely affected. If a carrier partner relationship terminates or there is loss of strategic support or alignment,
we may be
unable to transition to a new relationship without disruption, increased cost, lost profits, or lost market share, or a combination
of of
the foregoing.
We derive a large portion of our revenue from commissions on the sale of automotive insurance products in India, China, the U.S., U.K. and E.U. If a carrier were to experience liquidity problems or other financial (such as rating agency downgrades) or operational difficulties, we could encounter business disruptions as a result, and our results of operations may suffer.
As
a software business, we face risks of cyber-attacks, including ransomware and phishing attacks, social engineering attacks, computer
break-ins, theft, fraud, misappropriation, misuse, denial-of-service attacks, and other improper activity that could jeopardize the performance
of our platform and solutions and expose us to financial and reputational impact and legal liability, especially with regards to regulators
such as the FTC, which has become increasingly aggressive in prosecuting alleged failure to secure personal data as unfair and deceptive
acts or practices under the Federal Trade Commission Act the (“FTC Act”). In addition, each of Globalour Insurance Management
Limited and National Automobile Clubsubsidiaries may be subject to additional cyber-security risks,
borne of existing systems-wide vulnerabilities,
that could jeopardize the performance of their platforms and expose us to similar financial
and reputational impact and legal liability,
especially with regards to regulators such as the FTC.
Our
executive officers have limited experience in the management of a publicly traded company. Our management team may not successfully or
effectively manage a public company such as Roadzen that will be subject to significant regulatory oversight and reporting obligations
under U.S. securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could
be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will
result in less time being devoted to the management and growth of our company. We may not have adequate personnel with the appropriate
level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required
of public companies in the U.S. In addition, each of Globalour Insurance Management Limited and National Automobile Clubsubsidiaries may also have inadequate
internal controls over financial reporting required of public companies in the U.S.
The development and implementation of the standards
and controls necessary for us to achieve the level of accounting standards required
of a public company in the U.S. may require costs
greater than expected. It is possible that we will be required to expand our employee
base and hire additional employees to support our
operations as a public company, which will increase our operating costs in future periods.
The
current conflicts between Ukraine and Russia andRussia, between Israel and Hamas and between the U.S. and Iran have exacerbated market instability
and disrupted the global
economy.
The
current conflicts between Ukraine and Russia andRussia, between Israel and Hamas and U.S. and Iran have caused uncertainty about economic and political
stability, stability,
increasing volatility in the credit and financial markets, and disrupting the global economy. The U.S., the E.U., and several
other countries
are imposing far-reaching sanctions and export control restrictions on Russian entities and individuals. These sanctions
and export controls
may also contribute to higher oil and gas prices and inflation, which could reduce demand in the global automotive
sector and therefore
reduce demand for our solutions. There is also a risk that Russia, as a retaliatory action to sanctions, may launch
cyberattacks against
the U.S., the E.U., or other countries or their infrastructures and businesses. Additional consequences of the conflict
may include diminished
liquidity and credit availability, declines in consumer confidence, declines in economic growth, and various shortages
and supply chain
disruptions. While we do not currently directly rely on goods or services sourced in Russia or Ukraine and thus have
not experienced
any direct disruptions, we may experience indirect disruptions in our supply chain. Any of the foregoing factors, including
developments developments
or effects that we cannot yet predict, may adversely affect our business, results of operations, and financial condition.
As
a managing general agency/underwriter in the U.S. and U.K./E.U. market,markets, and an insurance broker in India, we operate in a highly regulated
environment environment
for our insurance product distribution and face risks associated with compliance requirements, some of which cause us to
make judgment
calls that could have an adverse effect on us.
We do not hold a controlling equity interest in our Chinese subsidiary and rely on contractual and governance arrangements for consolidation, which may be less effective than direct ownership and may be challenged under PRC law.
Effective April 1, 2025, we began consolidating the financial results of Daokang (Beijing) Data Science Company Limited (“Daokang”), a company organized under the laws of the People’s Republic of China (the “PRC”), as a variable interest entity (“VIE”) under U.S. generally accepted accounting principles. We hold a 34.5% equity interest in Daokang and consolidate its results based on a combination of board, governance, and management rights, including a tiebreaking vote in the event of a deadlock and sole authority to designate Daokang’s Chief Executive Officer. These arrangements may not be as effective as direct equity ownership in providing operational control. If the other shareholders of Daokang, the directors designated by them, or the Daokang Chief Executive Officer fail to act in accordance with our instructions, fail to perform their obligations under these arrangements, or contest the validity or enforceability of these arrangements, we may be required to incur substantial costs to enforce our rights, and we may be unable to do so in a timely manner or at all. The PRC legal system is based on written statutes, and prior court decisions have limited precedential value. Uncertainties in the PRC legal system could limit our ability to enforce these arrangements, and any such failure could materially and adversely affect our business, financial condition, results of operations, and the value of our securities.
Changes in PRC laws, regulations, or government policies, or actions by PRC regulatory authorities, could materially affect Daokang’s operations and our ability to consolidate Daokang’s financial results.
The PRC government has broad authority to regulate companies operating in the PRC, including in areas relating to data, cybersecurity, foreign investment, anti-monopoly review, and the structure of overseas-listed issuers with PRC operations. The PRC government has in recent years adopted or proposed a number of measures that may affect companies with operations in the PRC, including the Cybersecurity Law, the Data Security Law, the Personal Information Protection Law, measures of the Cyberspace Administration of China relating to cybersecurity review and cross-border data transfers, and the China Securities Regulatory Commission’s (“CSRC”) Trial Administrative Measures of the Overseas Securities Offering and Listing by Domestic Companies that took effect on March 31, 2023. The interpretation and enforcement of these laws and regulations remain subject to substantial uncertainty. If the PRC government determines that our consolidation of Daokang, the contractual and governance arrangements relating to Daokang, or any of Daokang’s business activities are not in compliance with applicable PRC laws and regulations, or if these laws and regulations change or are interpreted differently in the future, we could be required to restructure our arrangements with Daokang, deconsolidate Daokang, divest our interest in Daokang, or take other actions that could result in significant disruption to our business and a material and adverse impact on our financial condition and results of operations. We may also be required to obtain permissions or approvals from PRC regulatory authorities, including the CSRC and the Cyberspace Administration of China, in connection with our existing or future operations or capital markets activities, and we cannot assure investors that we will be able to obtain such permissions or approvals in a timely manner, or at all.
The Holding Foreign Companies Accountable Act and related developments could result in our securities being prohibited from trading in the United States if the Public Company Accounting Oversight Board is unable to inspect our auditors.
The Holding Foreign Companies Accountable Act, as amended (the “HFCAA”), and related rules adopted by the U.S. Securities and Exchange Commission and the Public Company Accounting Oversight Board (the “PCAOB”) provide that if the PCAOB is unable to inspect or investigate completely an auditor that has issued an audit report for a U.S.-listed issuer for two consecutive years, the issuer’s securities will be prohibited from trading on a U.S. national securities exchange or in the over-the-counter market. In December 2022, the PCAOB announced that it had secured access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong; however, the PCAOB has indicated that this determination is subject to ongoing reassessment and could be reversed if obstructions to its access arise. If the PCAOB in the future is unable to conduct full inspections or investigations of any audit firm that performs audit work in connection with Daokang’s financial statements, or of our principal auditor to the extent any portion of its work is performed in the PRC or Hong Kong, our securities could become subject to a trading prohibition under the HFCAA, and the market price and liquidity of our securities could be materially and adversely affected.
Restrictions on the movement of cash into and out of the PRC may limit our ability to use Daokang’s cash flows to fund our operations or meet our obligations.
The PRC government imposes controls on the convertibility of the Renminbi into foreign currencies and the remittance of currency out of the PRC. Daokang’s revenue is generated in Renminbi, and Daokang is subject to PRC laws and regulations governing dividend distributions, statutory reserve requirements, foreign exchange administration, and withholding tax on payments to non-PRC affiliates. As a result, our ability to access cash generated by Daokang to fund operations at our holding company or other subsidiaries, to service indebtedness, or to make distributions to our shareholders may be limited, delayed, or subject to additional taxation. In addition, the contractual and governance arrangements through which we consolidate Daokang may further constrain the timing or manner in which we are able to access Daokang’s cash flows. Any inability to move cash out of the PRC efficiently, or any change in PRC laws or regulations affecting cash transfers, could adversely affect our liquidity, capital structure, and ability to meet our obligations.
The accounting for our consolidation of Daokang involves significant judgment and estimates, and adjustments during the measurement period or in future periods could materially affect our reported results.
The accounting for our consolidation of Daokang, including the determination that we are the primary beneficiary of Daokang for accounting purposes, the remeasurement of our previously held equity interest, the recognition and measurement of identifiable assets acquired and liabilities assumed, and the recognition of any goodwill or bargain purchase gain, involves the application of significant judgment and the use of estimates regarding fair value. The initial accounting may be recorded on a provisional basis and is subject to adjustment during the measurement period. Subsequent changes in facts and circumstances, including changes in the contractual or governance arrangements, the loss of any of the rights on which our consolidation conclusion is based, or a determination that Daokang is no longer a variable interest entity or that we are no longer its primary beneficiary, could require us to deconsolidate Daokang or to reassess the carrying value of related assets and liabilities, any of which could have a material effect on our financial position and results of operations. In addition, the carrying value of any goodwill or long-lived assets recognized in connection with the consolidation will be subject to impairment testing, and the prior impairment of our investment in Daokang as of March 31, 2025 reflects the historical difficulty we have experienced in obtaining reliable financial information from Daokang.
As
of March 31, 2025, we had no U.S. patents and pending applications, and three registered non-U.S. patents, one registered non-U.S. design
and two pending non-U.S. patent applications.
As
of March 31, 2024,2026, we had no U.S. patents and pending applications, and threenine registered non-U.S. patents, one registered non-U.S.
design design
patent and twofive pending non-U.S. patent applications. There can be no assurance that our patent applications will result in
issued patents. Even if we continue to seek patent protection in the future, we may be unable to obtain further patent protection
for for
our technology. There can also be no assurance that our patents or application will be equally enforceable or otherwise
protected by
the laws of non-U.S. jurisdictions.
As
a public company, we incur significant legal,
accounting and other expenses that we did not incur as a private company, including costs
associated with public company reporting requirements.
The Sarbanes-Oxley Act of 2002, as amended, or Sarbanes-Oxley Act, as well as
rules subsequently adopted by the SEC and The Nasdaq Global
Market to implement provisions of the Sarbanes-Oxley Act, impose significant
requirements on public companies, including requiring establishment
and maintenance of effective disclosure and financial controls and
changes in corporate governance practices. Further, in July 2010,
the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the
Dodd-Frank Act, was enacted. There are significant corporate governance
and executive compensation related provisions in the Dodd-Frank
Act that require the SEC to adopt additional rules and regulations in
these areas, such as “say on pay” and proxy access.
Emerging growth companies may implement many of these requirements over
a longer period of up to five years from the pricing of thistheir initial public
offering. We intend to take advantage of these extended transition periods
but cannot guarantee that we will not be required to implement
these requirements sooner than budgeted or planned and thereby incur unexpected
expenses. Stockholder activism, the current political
environment and the current high level of government intervention and regulatory
reform may lead to substantial new regulations and disclosure
obligations, which may lead to additional compliance costs and impact the
manner in which we operate our business in ways we cannot currently
anticipate.
We
are an emerging growth company, as defined
in the Jumpstart Our Business Startups Act, or JOBS Act, enacted in April 2012. For as long
as we continue to be an emerging growth company,
we intend to take advantage of exemptions from various reporting requirements that are
applicable to other public companies that are
not emerging growth companies. These include, but are not limited to, exemption from auditor
attestation requirements of Section 404
of the Sarbanes-Oxley Act, reduced executive compensation disclosure obligations, in this Annual
Report, our periodic reports and our
proxy statements, and an exemption from the requirements of holding nonbinding advisory votes on
executive compensation, and stockholder
approval of any golden parachute payments not previously approved. We could be an emerging growth
company forthrough upMarch to31, five years following
the year in which we complete this offering,2027, although circumstances could cause us to lose that
status earlier. We will remain an emerging
growth company until the earlier of: (i) the last day of the fiscal year in which we have
total annual gross revenues of $1.235 billion
or more; (ii) the last day of our fiscal year following the fifth anniversary of the date
of the completion of our initial public offering;
(iii) the date on which we have issued more than $1 billion in non-convertible debt
during the prior three-year period; or (iv) the date
on which we are deemed to be a large accelerated filer under the rules of the SEC.
Management's Discussion & Analysis (MD&A)
New heading “Secured, Non-Convertible 2022 Debentures”
New heading “Junior Convertible January 2026 Debentures”
Removed heading “March Junior Notes”
Largest changes
“Upon the occurrence of an Event of Default (as defined in the November Notes), the November Holders will have the right to (i) either require the Company to redeem all or any portion of the November Notes, (ii) or, in the case of a failure to make a required quarterly payment under the November Notes, convert all or any portion of the November Notes at a price equal to the Event of Default Conversion Price (as defined in the November Notes). …”see in full comparison
“Upon the occurrence of an Event of Default (as defined in the January Notes), the January Holders will have the right to (i) either require the Company to redeem all or any portion of the January Notes, (ii) or, in the case of a failure to make a required quarterly payment under the January Notes, convert all or any portion of the January Notes at a price equal to the Event of Default Conversion Price (as defined in the January Notes). …”see in full comparison
“Upon the occurrence of an Event of Default (as defined in the Junior Notes), the Investor may (i) either require the Company to redeem all or any portion of the Junior Notes, (ii) or, in the case of a failure to make a required quarterly payment under the Junior Notes, convert all or any portion of the Junior Notes at a price equal to the Event of Default Conversion Price (as defined in the Junior Notes). …”see in full comparison
“During the year ended March 31, 2025, the Company recorded a full impairment charge of $1.2 million related to its joint venture investment in China. This decision was driven by escalating macroeconomic and geopolitical tensions, particularly tariff-related uncertainties between the U.S. and China, which have adversely affected the Company’s ability to exercise operational influence and access timely and reliable information about the joint venture’s financial position. …”see in full comparison
“On January 20, 2026, the Company and the Investor entered into an Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Amendment”), which amended certain of the terms of the junior convertible notes issued to the Investor in November 2025 (the “November Notes”) pursuant to the terms of that certain Securities Purchase Agreement dated as of November 20, 2025, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025. …”see in full comparison
“Our U.S. managing general underwriter (“MGU”) subsidiary holds insurance producer licenses in California, Texas, Illinois, and New Jersey, and operates under Coverholder authority granted by Lloyd’s of London, which permits it to bind risks on behalf of one or more Lloyd’s syndicates within the scope of a binding authority agreement. Our U.S. MGU operations are subject to extensive regulation at the U.S. …”see in full comparison
Full comparison: every changed paragraph (73)
Our
operations are global, and our partners consist of market-leading insurance companies, fleets and automotive original equipment manufacturers
(“OEMs”) and carmakers, including AXA, SCOR, Arch, Société Générale, Jaguar Land Rover, Audi,
Mercedes, Volvo
and several others. Our subsidiary in the U.K., operates through a specialist Managing General Agent (“MGA”)
based in Coventry,
which provides auto insurance, extended warranties, and claims management services to insurers, automotive dealers,
manufacturers, and
fleet operators. This MGA leverages its regulatory license to underwrite and service policies locally while utilizing
third-party licenses
to deliver solutions globally. It acts as a delegated authority on behalf of insurers, managing policy sales and
claims adjudication via
its brokerage platform. Revenue is generated through commissions and administrative fees tied to Gross Written
Premium (“GWP”),
with specialty contracts typically structured over five-year terms. Roadzen’s subsidiary in the U.S.,
operates a licensed auto club
based in Burlingame, California that specializes in commercial roadside assistance (“RSA”)
and claims management. With a robust
network of over 75,000 service providers nationwide, it offers towing, transportation, and first
notice of loss (“FNOL”) services
to government fleets, enterprises, insurers, and auto manufacturers. We also operate a California
licensed insurance broker and managing general underwriter based in San Diego, California, after acquiring a majority stake in the quarter
ended December 31, 2025. These capabilities support our comprehensive suite of mobility and
insurance infrastructure services across
North America. Roadzen’s subsidiary in India operates as a licensed insurance broker providing
distribution and servicing of motor
insurance products, including RSA, vehicle inspection, and claim facilitation. We also operate a workshop management platform, digitizing
end-to-end auto repair across a network of more than 1,200 verified garages and car repair workshops. Our India operations
also serve
as the company’sCompany’s global technology headquarters, where our product, engineering, and AI teams develop and scale the core platforms
that power our insurance and mobility services worldwide. This integrated approach allows us to drive innovation and operational efficiency
across all markets we serve.
In the People’s Republic of China, we operate a data analytics and AI-enabled software company serving the insurance and mobility value chain in the Greater China market.
Our
mission is to build the leading company at
the intersection of artificial intelligence (AI), insurance and mobility. To further our mission,
we have built a pioneering lab focused
on fundamental and applied AI research. We work on core research areas in computer vision, generative
AI, and traditional machine learning
to develop product experiences that improve the safety, convenience, and protection of millions
of drivers across the world. Roadzen
is a founding member of the AI Alliance fostering safe, responsible, and open source development
alongside industry leaders such as Meta,
IBM, Hugging Face, Stability AI, AMD, Service Now, and others. Our approach to build precision
AI models in insurance and mobility has
won several industry accolades. Roadzen achieved significant industry recognition for its advancements
in AI and technology during FY 2024-25. Honors included ‘Breakthrough in Computer Vision’ (FE AICONIC Summit & Awards
included2026), InsurTech Solution of the Year (Fintech Breakthrough Awards 2026), ‘Best Insurtech’ (Bharat Fintech Summit Awards
2026), ‘Best AI in Deep Tech’ at the AI Awards Summit 2025 by Entrepreneur India and secured a spot on the Fintech40 Index
by L’Observatoire de la Fintech. It was named the ‘World’s Top InsurTech’ by CNBC in 2024, ‘Most Innovative
Use of AI’ by Financial Express at the FE Futech Awards 2024 and won the Gold Stevie Award for its xClaimClaims insurance solution at
the International Business Awards 2024. Additional recognitions included ‘Excellence in InsurTech’ by the India FinTech Forum
(IFTA 2024), ‘Best Use of AI in Insurance’ at the Global AI Summit & Awards (GAISA 2024), and ‘Best Product and
Business Team’ at the World Auto Forum 2024. Roadzen also won ‘Best Use of Technology’ at the Entrepreneur Awards 2024
and ‘Most Innovative Company’ at the World Finance Innovation Awards 2024.
The
FCA has the
authority to suspend the sale of any insurance product sold within the U.K. and for which it has oversight, if it does not
believe a
firm or a product is protecting the interests of U.K. consumers. EffectiveFor examples, in February 2024, the FCA paused all sales of
the Guaranteed
Asset Protection (“GAP”) product, a key contributor to our operations in the U.K., directing all insurers,
including our
insurance partner, to temporarily cease selling the GAP product. The regulator mandated insurers to make a resubmission,
or new GAP
proposal, outlining product features, coverages and pricing for approval by the FCA before sales of the GAP product could
be beresumed. Although our insurance partner, which is obligated to adhere to FCA guidelines, eventually received approval to sell GAP
resumed.products, the resubmission and approval process had a significant impact on our revenue, financial performance, and overall profitability.
Although our insurance partner, which is obligated to adhere
to FCA guidelines, received approval to sell GAP products, the resubmission and approval process had a significant impact on our revenue, financial performance, and overall profitability.
Our
auto club subsidiary in the U.S. is licensed as an auto
club in California, which exposes Roadzen to a distinct set of risks due to the stringent regulatory
landscape enforced by the California
Department of Insurance (“CDI”). Compliance with these regulations is paramount, as
they govern a wide spectrum of our activities,
including membership services, claims management, and financial integrity.
Our U.S. managing general underwriter (“MGU”) subsidiary holds insurance producer licenses in California, Texas, Illinois, and New Jersey, and operates under Coverholder authority granted by Lloyd’s of London, which permits it to bind risks on behalf of one or more Lloyd’s syndicates within the scope of a binding authority agreement. Our U.S. MGU operations are subject to extensive regulation at the U.S. state level, including licensing, financial responsibility, fiduciary handling of premium and claim funds, recordkeeping, reporting, market conduct, producer compensation, and, in certain states, specific managing general agent statutes modeled on the National Association of Insurance Commissioners’ Managing General Agents Act. Our Coverholder authority is governed by the binding authority agreements with our Lloyd’s carriers and by the underwriting, audit, conduct, complaint-handling, sanctions, and reporting standards established by Lloyd’s and overseen in the United Kingdom by the Prudential Regulation Authority and the FCA. Our financial performance depends on our ability to maintain these licenses and authorities in good standing, to operate within delegated underwriting authority and aggregate limits set by our carriers, and to comply with applicable state and Lloyd’s requirements. Changes in state insurance laws or regulations, modifications to Lloyd’s Coverholder or delegated authority standards, loss or suspension of a license or Coverholder authority, reductions or non-renewals of delegated underwriting authority by our carrier partners, adverse findings from regulatory examinations or carrier audits, or changes in commission structures or premium volumes in the lines we administer could each have a material effect on the revenue, operating results, and cash flows. We also incur ongoing compliance costs to support our multi-jurisdictional licensing footprint, which we expect to increase as we expand into additional states and add carrier relationships.
Revenue
increased declined by $2.4$10.7 million, representing
aor 5% decrease24.2%, for the year endingended March 31, 2025,2026, compared to the previousprior year. This reduction was primarily due to the suspension of
the GAP product in the U.K.
Commission and Distribution Income increased $2.5 million, or 10.9%, for the year ended March 31, 2026, compared to the prior year. The growth was primarily driven by strategic expansion initiatives, including the acquisition of Elite Cover Insurance in the U.S., which contributed approximately $1.0 million in revenue, and an asset acquisition in India, which contributed approximately $1.5 million. The increase was partially offset by a decline in revenue from the U.K. market; however, this impact was mitigated by continued organic growth in India, supporting the overall increase in Commission Distribution income during the year.
Revenue from the Insurance-as-a-Service (IaaS) platform increased by approximately $8.2 million, or 39.2%, for the year ended March 31, 2026, compared to the prior year. The increase was primarily driven by the consolidation of our VIE in China, which contributed approximately $3.0 million in revenue, and the acquisition of a vehicle care business in India, which contributed approximately $0.7 million for the 3 months period. The remaining increase was attributable to the continued expansion of our existing business operations, including growth from our current customer base and increased adoption of our IaaS platform offerings.
Commission and
Distribution Income saw a decrease of $7.0 million, or 23%, over the same period last year. This drop can be attributed to the suspension of
the GAP product in the U.K., which took effect in February 2024, offset by growth in other geographies.
Conversely, revenue from the Insurance as a Service
(IaaS) platform experienced significant growth, increasing by $4.6 million, or 29%, for the year ending March 31, 2025. This growth was
driven by higher penetration among existing clients and the addition of new clients.
Cost of services increased $2.4 million, or 13.0%, for the year ended March 31, 2026, compared to the prior year. The increase was primarily driven by the consolidation of our VIE China, which contributed approximately $1.5 million, and the acquisition of a Vehicle Care business in India, which contributed approximately $0.4 million. The remaining increase was attributable to the growth and expansion of our existing business operations, including higher service delivery costs associated with increased business volumes.
Cost of services increased $0.7 million, or
4%, for the year ending March 31, 2025 compared to the prior year. This increase was primarily attributed to the
inclusion of costs from NAC, which was acquired in June 2023 and not included April and May 2023.
Research and development expense decreased $3.4 million, or 89.2%, for the year ended March 31, 2026, compared to the prior year. The decrease was primarily driven by a reduction of approximately $2.6 million in non-cash compensation expense related to RSU grants, an increase of approximately $0.6 million in capitalized development costs compared to the prior period, and a decrease of approximately $0.2 million in technology personnel and consulting expenses. The reduction reflects lower share-based compensation expense and a greater allocation of eligible development costs to capitalized assets, along with efficiencies in technology-related spending during the period.
Research and development expense decreased $1.2 million, or 24%, for the year ending March 31, 2025 compared to the prior year. This reduction was primarily due to a $0.8 million reduction in technology personnel and consultant expense and a $0.4 million
decrease in non-cash compensation expense related to RSU grants.
Sales
and marketing expense decreasedincreased $4.3
$0.2 million, or 13%,0.8%, for the year ended March 31, 20252026, compared to the prior year. ThisThe reductionincrease was primarily attributed
attributable to lowerhigher marketing and business
development expenses inincurred to support the U.K. following the suspensiongrowth of theour GAPdistribution product,income alongand withexpand market reach. This increase was partially offset
by a $0.5decrease of approximately $3.6 million decrease
in non-cash compensation expense related to RSU grants.grants compared to the prior period.
General and administrative expense decreased $35.6 million, or 69.0%, for the year ended March 31, 2026, compared to the prior year. The decrease was primarily driven by a reduction of approximately $40.7 million in non-cash compensation expense related to RSU grants. The decrease was partially offset by an increase in expenses of approximately $1.5 million due to the consolidation of our VIE in China and approximately $0.4 million related to the acquisition of EliteCover. The remaining variance was attributable to changes in routine operating activities during the period.
General and
administrative expense decreased $14.3 million, or 22%, for the year ended March 31, 2025 compared to the prior year. This reduction
was mainly due to a decrease of $8.1 million in non-cash RSU expense, a $4.9 million decrease in provisions for doubtful accounts
(which includes $2.8 million from preferred stock issuance before the Business Combination and $2.1 million in advances to
deconsolidated subsidiaries for working capital), coupled with efforts in cost
discipline and lower headcount.
Depreciation and amortization decreased byincreased $0.2
million million, or 8%11.1%, for the
year ended March 31, 2025,2026, compared to the same period in the prior year.
Interest
expense increased $0.9$4.0 millionmillion, or 42% increase123.2%, for the year ended March 31, 20252026, compared to the same period in the prior year primarily due to an increase in borrowings
from banks and other parties.
LossFair on fair valuationvalue changes in financial
instruments decreased by $4.6
millionapproximately $10.9 million, or 24%,73.2%, for the year ended March 31, 20252026, compared to the prior yearyear. The decrease
was primarily due to
the lower fair marketvalue valuationadjustments ofrecognized ourduring Forwardthe Purchasecurrent Agreement,period for the Company’s convertible promissory
notes, notes,share warrants, and shareforward warrants.purchase agreement, as compared to the prior-year period.
The prior-year period included significant fair value remeasurement impacts arising from changes in the valuation of these financial instruments, which resulted in higher gains/losses compared to the current period.
The Company evaluates its non-marketable equity investments for impairment
at each reporting period through a qualitative
assessment thatof considersrelevant variousimpairment indicators, including significant adverse changes in the
investee’s business,business performance, operating
environment, legal or regulatory environment,factors, or the abilityavailability to obtainof relevant financial information.
During the year ended March 31, 2026, the Company identified indicators of impairment related to its investment in Moonshot - Internet SAS (“Moonshot”) and recognized an impairment charge of approximately $0.3 million to write down the carrying value of the investment.
During the year ended March 31, 2025, the Company recorded a full impairment charge of $1.2 million related to its
joint venture investment in China. This decision was driven by escalating macroeconomic and geopolitical tensions, particularly tariff-related
uncertainties between the U.S. and China, which have adversely affected the Company’s ability to exercise operational influence
and access timely and reliable information about the joint venture’s financial position. In light of these factors and applying
the principle of prudence, management determined that the investment no longer meets the criteria for recoverability and accordingly recognized
a full impairment.
Other Incomeincome increaseddecreased by approximately
$6.2$4.7 million, or 743%,67.1%, for the year ended March 31, 20252026, compared to the prior year. ThisThe decrease was primarily drivenattributable byto a reduction
in the $7.6reversal million
provisionof andcertain short-termliabilities liabilityrelated releasesto duringpayables assumed in connection with the yearBusiness asCombination. partDuring the current period,
the Company recognized a write-back of ourapproximately Balance$2.5 Sheetmillion, clean-upcompared project,to partiallyapproximately offset by a
$0.7$6.5 million write-off of customer contractsrecognized in our U.K. subsidiary due to the pause in GAP sales.prior-year
period.
Additionally, the prior-year period benefited from approximately $0.7 million of income recognized from the write-off of customer contract-related balances, which did not recur during the current period.
Since
our incorporation,
we have financed our growth through a blend of equity, convertible instruments, debt (including working capital lines),
and customer
payments. As of March 31, 2025,2026, we have raised an aggregate of $52.0$69.7 million, net of issuance costs, through the issuance of
Ordinary Shares, convertible instruments and preferred stock of Roadzen DE.(DE). Our accumulated deficit
stood at $247.5 million as of March
31, 2026, compared to $224.3 million as of March 31, 2025 up from $151.6 million from the previous year.2025. These accumulated deficitdeficits stem from
substantial operating losses, which stems
from fair valuation, vesting of RSU, impairment of investment and intangible assets, transaction costs arose from business combination.
These losses have been detailed on the table below. We anticipate that we will continue to experience operating losses and generate negative
cash flows from operations
over an extended period due to the planned investments in our business. Consequently, we will need to secure
additional capital
resources to support the execution of our strategic initiatives for growing our business in the coming years.
For the year ended March
31, 2025, net cash used in operating activities was $18.1 million, $1.1 million decrease compared to $19.2 million for the year
ended March 31, 2024. This increase primarily reflects a combination of higher net losses and changes in working capital during the current period.
For
the year ended March 31, 2026, net cash used in operating activities was $20.3 million, compared to $18.1 million for the year
ended March 31, 2025. The cash outflow in the
year ended March 31, 20252026 was primarily driven by a net loss of $73.1$22.5 million,
and net cash outflows of $2.4$4.0 million resulting from
changes in operating assets and liabilities, including increased receivables and lower payables.liabilities. These outflows were partially
offset by non-cash adjustments totaling $57.4$6.3 million.
Cash generatedused from
in investing activities was $0.1approximately $0.9 million for the year ended March 31, 2025,2026. consistedThe cash outflow
was primarily attributable to the capitalization of $ 0.4approximately
$1.0 million ofin capitalsoftware expendituredevelopment forexpenditures, new
officeprimarily facilities,comprising partiallypersonnel offsetcosts by receipts from investmentsincurred in mutualthe fundscreation (heldand for sale)enhancement of $0.3 million.software
assets.
These outflows were partially offset by proceeds of approximately $0.1 million from the sale of investments in mutual funds classified as held for sale.
Cash
used in investing activities was $6.7$0.1 million
for the year ended March 31, 2024,2025, which primarily consisted of $5.7$0.4 million of capital
expenditure for thenew acquisitionsoffice offacilities, GIMpartially andoffset NAC,by $0.5receipts millionfrom consisting
of an investment madeinvestments in a mutual fundfunds (held for sale), and $0.5 million of capital$0.3 expenditures for additional office facilities.million.
We
have generated
negative cash flows from operations since our inception and have supplemented working capital through net proceeds from
the issuance
of Ordinary Shares as well as the issuance of debt. Cash provided by financing activities was $11.7$21.4 million for the year
ended March
31, 2025,2026, which consisted primarily of $7.1$6.5 million from the issuance of Ordinary Shares, $1.0$6.6 million from theissuance forwardof purchase
agreementequity shares of subsidiary company and $3.7$8.3 million from loans from banks and other parties.
Cash
provided by financing activities was $25.4
$11.7 million for the year ended March 31, 2024,2025, which consisted primarily consisted of $6.1$7.1 million of proceeds from
the issuance of commonOrdinary andShares, preferred
stock of Roadzen (DE), $3.8$1.0 million from the forward purchase agreement and $15.5$3.7 million from loans from banks and other parties.
On
January 30, 2024, the Company and the Seller
entered into an amendment to the Forward Purchase Agreement (the “Amendment”).
The Amendment amends the section of the Forward
Purchase Agreement regarding a Prepayment Shortfall by providing that the Company has
the option, at its sole discretion, at any time
up to 45 days prior to the Valuation Date, to request up to $5 million in Prepayment
Shortfall via ten separate written requests to Seller
in the amount of $500,000 each (each, an “Additional Shortfall Request”),
provided that at the time of any Additional Shortfall
Request (i) Seller has recovered 117% of the prior Additional Shortfall Request,
if any, via Shortfall Sales and (ii) the VWAP Price
over the ten trading days prior to such Additional Shortfall Request multiplied by
the then current Number of Shares less Shortfall Sale
Shares held by Seller is at least seven times greater than such Additional Shortfall
Request. In addition, the Amendment amends the section
of the Forward Purchase Agreement regarding Prepayment Shortfall Consideration
by eliminating the 180-day period following a Trade Date
before Seller may commence selling Recycled Shares and by permitting such sales
without payment by Seller of any Early Termination Obligation
until such time as the proceeds from such sales equal 117% (instead of
100% as originally provided in the Forward Purchase Agreement)
of the Prepayment Shortfall. During the year ended March 31, 2025,2026, anthe
Company did not receive any additional $1 million was receivedpayments from the Seller,Seller; bringing the
total cash receipts toremain at $4.8 million.
Secured, Non-Convertible 2022 Debentures
One of our material subsidiaries issued Secured, Non-Convertible Debentures with NP1 Capital Trust with an aggregate principal amount of $3.7 million during the fiscal year ended March 31, 2023 with varying maturity dates between January 2024 and July 2024 and interest rates ranging from 19.25% to 20.00% per year. On September 30, 2024 the Company entered into an amendment agreement restructuring the principal repayments and extending the maturity date to March 31, 2025. The Company did not honor the repayment of the above debentures as of the amended date, and has obtained an extension from the lender up to November 30, 2025. In October 2025, the Company entered into negotiations with the lender to settle all principal and accrued interest, including late payment charges, partly in cash and partly in equity of the Company’s Indian subsidiary. During the quarter, the Company repaid an aggregate amount of $1,289,867 towards the outstanding secured debentures. As of the reporting date, the outstanding balance was $428,729.
On November 4, 2025, the Company announced it had reached an agreement in principle with Mizuho to further extend the maturity date from December 31, 2025 to June 30, 2027. On January 10, 2026, and again on February 9, 2026 while Amendment No. 4 to the senior secured notes was being drafted, Mizuho granted to the Company a waiver of payment until January 31, 2026 and then February 28, 2026. On June 26, 2026 the Company and Mizuho entered into Amendment No. 4 to the Note Purchase Agreement, extending the maturity date to July 7, 2027. See Item 9B below for more information.
The
December 2023 Convertible Debentures bear
interest, in arrears, at a rate of 13% per annum, payable semi-annually commencing on June
15, 2024, and maturesmatured on December 15, 2025.
Interest is payable in kind, subject to the right of the Company to make any interest payments
in cash. The Debentures are convertible
into the Company’s Ordinary Shares, at the election of the holder at any time at an initial
conversion price of $10.00 per Ordinary
Share (the “Conversion Price”). The Conversion Price is subject to customary adjustments
for stock dividends, stock splits,
reclassifications and the like. In addition, if the average volume weighted average price of the Ordinary
Shares for the 30 trading days
immediately preceding December 15, 2024 (the “Average VWAP”) is less than the Conversion Price
then in effect, the Conversion
Price will be adjusted to an amount equal to such Average VWAP, subject to a floor of 85% of the Conversion
Price then in effect. In
addition, as the Average VWAP was less than the Conversion Price then in effect, the Conversion Price was adjusted
to $8.50, an amount
equal to 159,995 Ordinary Shares, as of December 15, 2024. The Company has the right to require the Debentures to
be converted into Ordinary
Shares if the closing price of the Ordinary Shares exceeds 130% of the then-applicable Conversion Price for
any 20 trading days within
a consecutive 30 trading day-period.
As of the reporting date, the Company has not honored the repayment and no conversion option under the debentures had also been exercised.
The
2024 SPA Notes bear interest at a rate of
17.5% per annum and mature on the six-month anniversary of funding of the respective note (the
“Initial Rate Adjustment Date”).
Interest is payable in cash or in kind, at the option of the Company, on each three month
anniversary of funding through the Initial
Rate Adjustment Date (after which date all interest is payable in cash unless the parties
agree to payment in kind). The Company’s
failure to repay all principal and accrued interest by the Initial Rate Adjustment Date
would not constitute an event of default under
the applicable 2024 SPA Note, however, the interest rate payable under such 2024 SPA Note
would increase on such date to 19.5% per annum
going forward, and thereafter would increase by an additional 200 basis points on each
monthly anniversary of the Initial Rate Adjustment
Date until each of the respective 2024 SPA Notes is paid in full, subject to a maximum
interest rate of 29.5% per annum. Following the
Initial Rate Adjustment Date, all unpaid principal and accrued interest would be payable
within five business days of the holder’s
written demand. If any interest under the 2024 SPA Notes is paid in kind, such payment
would be made through the issuance of that number
of the Company’s ordinary shares, $0.0001 par value per share (“Ordinary Shares”),
Shares, calculated by dividing the amount
payable by the lowest of (i) $8.00, (ii) the volume-weighted average price (“VWAP”)
of the Ordinary Shares over the 60 trading
days ending three trading days prior to the interest payment date, (iii) the opening price
per share of the Ordinary Shares in any public
offering of Ordinary Shares after the issuance of the respective 2024 SPA Notes, and (iv)
the price per Ordinary Share after market close
on the first day of trading following any such public offering of Ordinary Shares.
During the quarter ended December 31, 2025, the Company paid the full principal and all accrued interest for the March 2024 Note sold to Krishnan-Shah Family Partners, LP, and one March 2024 Note sold to Ms. VedBrat was partially paid, with the balance paid off subsequently to the reporting date. As of the reporting date, the outstanding balance on the remaining note was $668,258.
Secured,Junior
Convertible Non-ConvertibleNovember 20222025 Debentures
On November 20, 2025, the Company entered into a securities purchase agreement (the “November SPA”) with an institutional investor (the “Investor”) under which the Company agreed to issue and sell, in a registered public offering, junior convertible notes for up to an aggregate principal amount of $5,555,555 (each, a “November Note” and collectively, the “November Notes”) that may be convertible into the Company’s Ordinary Shares. On November 20, 2025, the Company completed the sale and issued the November Notes to the Investor.
The November Notes were sold for a gross purchase price of $5,000,000 before fees and other expenses. The November Notes will mature eighteen months from the date of issuance and will bear interest at a rate of 14% per year (increasing to 18% upon the occurrence and during the continuation of an event of default). $925,000 of the principal amount of the November Notes (less any portion thereof previously converted by the holders), together with accrued but unpaid interest, is payable quarterly, commencing three months after the date of issuance. The November Notes will have an initial conversion price of $2.25 (the “November Conversion Price”) and will be convertible at any time, in whole or in part and subject to certain beneficial ownership limitations, at the election of the holders. The November Conversion Price is subject to customary adjustments upon any stock split, stock dividend, stock combination, recapitalization or similar event. The Company may redeem all or any portion of outstanding November Notes at any time upon at least five trading days’ written notice by paying an amount equal to the principal amount of the November Notes being redeemed, together with interest accrued on such principal amount through the date of redemption, and additional interest that would accrue on such principal amount through the maturity date (the “November Make Whole Amount”).
Pursuant to the terms of the November Notes, the Company will agree not to effect the conversion of any portion of the November Notes, and the holders of the November Notes (the “November Holders”) will not have the right to convert any portion of the November Notes, to the extent that after giving effect to such conversion, each November Holder together with the other Attribution Parties (as defined in the November Notes) collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately after giving effect to such conversion. Upon delivery of a written notice to the Company, the November Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease shall apply only to the November Holder and the other Attribution Parties and not to any other holder of November Notes that is not an Attribution Party of the November Holder.
Upon the occurrence of an Event of Default (as defined in the November Notes), the November Holders will have the right to (i) either require the Company to redeem all or any portion of the November Notes, (ii) or, in the case of a failure to make a required quarterly payment under the November Notes, convert all or any portion of the November Notes at a price equal to the Event of Default Conversion Price (as defined in the November Notes). The Company will also agree not to enter into or be party to a Fundamental Transaction (as defined in the November Notes) unless (i) the Successor Entity (as defined in the November Notes) (if other than the Company) assumes in writing all of the obligations of the Company under the November Notes and the other Transaction Documents in accordance with the provisions of the November Notes prior to such Fundamental Transaction, or (ii) at or prior to the consummation of the Fundamental Transaction, the Company redeems the November Notes in full by paying to the holder an amount in cash representing all outstanding Principal, accrued and unpaid Interest (including Default Interest, as applicable) and November Make-Whole Amount.
On January 20, 2026, the Company and the Investor entered into an Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Amendment”), which amended certain of the terms of the junior convertible notes issued to the Investor in November 2025 (the “November Notes”) pursuant to the terms of that certain Securities Purchase Agreement dated as of November 20, 2025, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025. Among other things, the Amendment adds to the November Notes certain cross-default provisions with respect to the Notes and certain covenants contained in the Notes.
During the quarter ended March 31, 2026, the November Holders converted $100,000 of principal, accrued and unpaid interest and Make-Whole Amount, in exchange for 98,096 Ordinary Shares.
Junior Convertible January 2026 Debentures
On January 19, 2026, the Company entered into a securities purchase agreement (the “January SPA”) with an institutional investor (the “Investor”) under which the Company agreed to issue and sell, in a registered public offering, junior convertible notes (each, a “January Note” and collectively, the “January Notes”) for up to an aggregate principal amount of $5,555,555 that may be convertible into the Company’s Ordinary Shares. The closing of the issuance and sale of the Notes occurred on January 20, 2026.
The January Notes were sold for a gross purchase price of $5,000,000 before fees and other expenses. The January Notes will mature on June 20, 2027 and will bear interest at a rate of 14% per annum (increasing to 18% per annum upon the occurrence and during the continuation of an event of default). $925,000 of the principal amount of the January Notes (less any portion thereof previously converted by the holders), together with accrued but unpaid interest, is payable quarterly, commencing three months after the date of issuance. The January Notes will have an initial conversion price of $3.50 (the “January Conversion Price”) and will be convertible at any time, in whole or in part and subject to certain beneficial ownership limitations, at the election of the holders. The January Conversion Price is subject to customary adjustments upon any stock split, stock dividend, stock combination, recapitalization or similar event, as well as upon certain equity financings at a price below the January Conversion Price then in effect. The Company may redeem all or any portion of outstanding January Notes at any time upon at least 20 trading days’ written notice by paying an amount equal to the principal amount of the January Notes being redeemed, together with interest accrued on such principal amount through the date of redemption, and additional interest that would accrue on such principal amount through the maturity date (the “January Make Whole Amount”), subject to certain conditions, including that the volume weighted average price of the Ordinary Shares is less than the January Conversion Price then in effect.
Pursuant to the terms of the January Notes, the Company has agreed not to effect the conversion of any portion of the January Notes, and the holders of the January Notes (the “January Holders”) will not have the right to convert any portion of the January Notes, to the extent that after giving effect to such conversion, each January Holder together with the other Attribution Parties (as defined in the January Notes) collectively would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately after giving effect to such conversion. Upon delivery of a written notice to the Company, the January Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company and (ii) any such increase or decrease shall apply only to the January Holder and the other Attribution Parties and not to any other holder of January Notes that is not an Attribution Party of the January Holder.
Upon the occurrence of an Event of Default (as defined in the January Notes), the January Holders will have the right to (i) either require the Company to redeem all or any portion of the January Notes, (ii) or, in the case of a failure to make a required quarterly payment under the January Notes, convert all or any portion of the January Notes at a price equal to the Event of Default Conversion Price (as defined in the January Notes). The Company will also agree not to enter into or be party to a Fundamental Transaction (as defined in the January Notes) unless (i) the Successor Entity (as defined in the January Notes) (if other than the Company) assumes in writing all of the obligations of the Company under the Notes and the other Transaction Documents in accordance with the provisions of the January Notes prior to such Fundamental Transaction, or (ii) at or prior to the consummation of the Fundamental Transaction, the Company redeems the January Notes in full by paying to the holder an amount in cash representing all outstanding Principal, accrued and unpaid Interest (including Default Interest, as applicable) and January Make-Whole Amount.
On May 22, 2026, the Company entered into a Third Amendment to Securities Purchase Agreement and Junior Convertible Notes (the “Third Amendment”), which amended certain of the terms of (i) the November SPA, (ii) the November Note, and (iii) the January Note. Among other things, the Third Amendment amends the November Note to (i) change the dates on which the “Installment Amounts” otherwise due under the November Note on April 21, 2026 and May 21, 2026 are due to July 20, 2026, (ii) add a provision that would adjust the “Conversion Price” of the November Note in the event of certain equity financings below the Conversion Price then in effect, equivalent to the provision in the January Note and (iii) remove the provision that required the Company to use up to 25% of the net proceeds of “Subsequent Placements” to redeem all or a portion of the November Note. The Third Amendment also (i) changes the date on which the “Installment Amount” otherwise due under the January Note on May 20, 2026 is due to July 20, 2026, and (ii) extends the termination date of the Investor’s right to participate in certain financings by the Company to December 20, 2027. Also pursuant to the Third Amendment, the Company is required to use commercially reasonable efforts to obtain the approval, for purposes of Nasdaq Listing Rules, of its shareholders to issue a number of the Company’s Ordinary Shares upon conversion of the November Note and the January Note in excess of 20% of the total number of Ordinary Shares outstanding as of November 20, 2025.
One of our material subsidiaries issued Secured,
Non-Convertible Debentures with NP1 Capital Trust with an aggregate principal amount of $3.7 million during the fiscal year ended March
31, 2023 with varying maturity dates between January 2024 and July 2024 and interest rates ranging from 19.25% to 20.00% per annum. The
principal outstanding as of March 31, 2025 is $1.7 million. On September 30, 2024 the Company entered into an amendment agreement
restructuring the principal repayments and extending the maturity date to March 31, 2025. The Company has not honored the repayment of the above debentures as on the amended date but has obtained an extension
from the lender up to July 31, 2025. However, there is no new agreement in place.
On December 15, 2024, the Company entered into
an underwriting agreement with ThinkEquity LLC, relating to a firm commitment underwritten public offering (the “December Offering”)
of an aggregate of up to (i) 1,900,000 shares of the Company’s Ordinary Shares at a price to the public of $1.25 per share (the
“December Shares”), and (ii) pre-funded warrants (the “Pre-Funded Warrants” and, together with the December Shares,
the “December Securities”) to purchase 400,000 Ordinary Shares at a price to the public of $1.249 per Pre-Funded Warrant.
The closing of the December Offering occurred
on December 17, 2024. The gross proceeds to the Company from the sale of the December Securities, before deducting the underwriting discounts
and commissions and other estimated offering expenses payable by the Company, was $2,875,000.
What changed in the latest 10-Q
Risk Factors
New heading “The recent dismissal by the United States District Court for the Southern District of New York (“USDC NY”) of substantially all of our claims against Meteora, and the pleading-stage determinations underlying that dismissal, may prevent us from recovering amounts we believe are owed to us under the FPA and could adversely affect related claims.”
New heading “We have incurred, and expect to continue to incur, substantial legal fees and other expenses in connection with the Meteora litigation, and we may become liable for the fees and costs of Meteora if we do not prevail in one or more of these proceedings.”
New heading “Because our appeal of the USDC NY action and the Chancery Court action against us remain pending, the ultimate outcome of the Meteora litigation cannot presently be determined, and we may be required to pay damages to Meteora. In addition, and any recovery we may obtain in excess of the written-down carrying value of our FPA-related asset will not be recognized until realized.”
New heading “The write-down of our FPA-related prepaid asset resulted in a material non-cash charge to our results of operations for the quarter and reduced our reported equity, and further adjustments could be required in future periods depending on developments in the Meteora litigation.”
New heading “Publicity concerning the Meteora litigation could adversely affect our reputation and the market price and trading volume of our Ordinary Shares and Public Warrants.”
Removed heading “The unaudited financial information of the newly consolidated entities included in this filing is preliminary, and our actual financial condition and results of operations may differ materially.”
Removed heading “Our newly consolidated joint venture in China exposes us to significant geopolitical, regulatory, and economic risks that could adversely affect our business, results of operations, and financial condition.”
Removed heading “Our consolidation of the joint venture in China is based on board control rather than majority equity ownership, and changes in governance, regulation, or local enforcement could cause us to lose control or require deconsolidation.”
Largest changes
“During the quarter ended June 30, 2026, we recorded a non-cash write-down of our FPA-related prepaid asset to $914,726.53, resulting in a charge of approximately $5.9 million reflected in the Fair value losses in financial instruments carried at fair value in our condensed consolidated statement of operations, and a corresponding reduction in our reported total equity. The write-down was based on our assessment, under U.S. …”see in full comparison
“As a result of our recently consolidated joint venture in China, we are now subject to the economic, political, and regulatory conditions prevailing in that country. The relationship between the United States and the People’s Republic of China has become increasingly complex and, at times, adversarial. Ongoing trade tensions, evolving export controls, restrictions on technology transfers, sanctions, tariffs, and potential limitations on U.S. …”see in full comparison
“The write-down of our FPA-related prepaid asset resulted in a material non-cash charge to our results of operations for the quarter and reduced our reported equity, and further adjustments could be required in future periods depending on developments in the Meteora litigation.”see in full comparison
“As described in Part II, Item 1, “Legal Proceedings,” on July 9, 2026 the USDC NY granted Meteora’s motion to dismiss the claims asserted in our amended complaint against Meteora and its principals, including our claims for breach of contract, breach of the implied duty of good faith and fair dealing, securities fraud and violations of the RICO, through which we sought to recover the amounts we allege are owed to us under the FPA and its January 2024 amendment. The Company has filed an appeal to the United States Court of Appeals for the Second Circuit. …”see in full comparison
“Our consolidation of the joint venture in China is based on board control rather than majority equity ownership, and changes in governance, regulation, or local enforcement could cause us to lose control or require deconsolidation.”see in full comparison
“Because our appeal of the USDC NY action and the Chancery Court action against us remain pending, the ultimate outcome of the Meteora litigation cannot presently be determined, and we may be required to pay damages to Meteora. In addition, and any recovery we may obtain in excess of the written-down carrying value of our FPA-related asset will not be recognized until realized.”see in full comparison
Full comparison: every changed paragraph (25)
The recent dismissal by the United States District Court for the Southern District of New York (“USDC NY”) of substantially all of our claims against Meteora, and the pleading-stage determinations underlying that dismissal, may prevent us from recovering amounts we believe are owed to us under the FPA and could adversely affect related claims.
As described in Part II, Item 1, “Legal Proceedings,” on July 9, 2026 the USDC NY granted Meteora’s motion to dismiss the claims asserted in our amended complaint against Meteora and its principals, including our claims for breach of contract, breach of the implied duty of good faith and fair dealing, securities fraud and violations of the RICO, through which we sought to recover the amounts we allege are owed to us under the FPA and its January 2024 amendment. The Company has filed an appeal to the United States Court of Appeals for the Second Circuit. In reaching its decision, the USDC NY made determinations at the pleading stage regarding, among other things, the plain-language interpretation of the FPA and the effect of its merger and integration clause on prior term sheets and alleged oral representations, and concluded that certain of our fraud, misrepresentation and RICO theories were either duplicative of contract theories or barred under the Private Securities Litigation Reform Act. Although these determinations were made under a pleading standard that assumes the truth of our allegations, they may be cited by Meteora, or by other commercial counterparties, in future proceedings, and could affect our ability to prosecute the appeal, the pending Chancery Court action, or any related or subsequent litigation. Appeals of orders granting motions to dismiss are inherently uncertain, are decided on the pleadings without the benefit of a developed factual record, and may take a substantial period of time to resolve. If our appeal is unsuccessful, or is successful only in part, we may be unable to recover all or any portion of the amounts we believe are owed to us. The loss of such potential recovery could adversely affect our liquidity, results of operations and financial condition, and could require us to seek alternative sources of capital on less favorable terms, or in amounts less than we may require.
We have incurred, and expect to continue to incur, substantial legal fees and other expenses in connection with the Meteora litigation, and we may become liable for the fees and costs of Meteora if we do not prevail in one or more of these proceedings.
In connection with our appeal of the July 9, 2026 USDC NY order and the related action pending in the Chancery Court, we have incurred, and expect to continue to incur, substantial fees and disbursements payable to outside counsel, expert witnesses and other advisors, and we expect these expenditures to continue over an extended period. In addition, under applicable law, procedural rules, or the terms of the FPA or the Subscription Agreement, we may become liable for a portion of the prevailing party’s attorneys’ fees, costs and other litigation-related expenses in one or more of these proceedings. If our appeal to the Second Circuit is unsuccessful, or if the Chancery Court rules adversely to us on Meteora’s pending summary judgment application or in any subsequent phase of the Delaware action, our aggregate exposure in respect of legal fees, disbursements, costs and any fee-shifting or indemnification awards could be material. The ultimate magnitude of any such exposure cannot currently be ascertained, as it will depend on, among other factors, the final disposition of each proceeding, the timing and scope of any award, the volume of work performed by counsel through resolution, and the availability and terms of any applicable insurance. The Meteora litigation also requires significant management attention that would otherwise be devoted to our operations. Any material fee-shifting liability, or the cumulative cost of prosecuting and defending these matters, could have a material adverse effect on our results of operations, cash flows and financial condition in the periods in which such amounts are incurred or recorded.
Because our appeal of the USDC NY action and the Chancery Court action against us remain pending, the ultimate outcome of the Meteora litigation cannot presently be determined, and we may be required to pay damages to Meteora. In addition, and any recovery we may obtain in excess of the written-down carrying value of our FPA-related asset will not be recognized until realized.
Our appeal of the July 9, 2026 USDC NY order is at an early procedural stage, and the Chancery Court action, in which Meteora has sought, among other relief, a declaratory judgment that its obligations to us under the FPA are limited to $914,726.53, remains held in abeyance pending the Chancery Court’s decision on Meteora’s summary judgment application, which the Chancery Court advised the parties following the May 21, 2026 hearing would be rendered in no more than ninety days. Meteora is also seeking damages against us in the Chancery Court action. Litigation and appellate proceedings of this nature are inherently uncertain and are subject to numerous factors outside our control, including the appellate court’s interpretation of the FPA, the Subscription Agreement and the pleadings, the Chancery Court’s disposition of Meteora’s summary judgment application, any subsequent rulings and schedules in either forum, developments in discovery (if and when it occurs), and the availability and outcome of any further appellate review. As described in Note 5 to our condensed consolidated financial statements included elsewhere in this Quarterly Report, during the quarter we recorded a write-down of our FPA-related prepaid asset to $914,726.53, reflecting the amount that, based on currently available information, we consider supportable under U.S. generally accepted accounting principles. That accounting determination does not constitute a concession by the Company of its legal position in the appeal or in the Chancery Court action, in each of which we continue to seek, and to defend against Meteora’s efforts to limit, recovery in amounts materially in excess of $914,726.53. Consistent with U.S. generally accepted accounting principles, any recovery ultimately obtained in excess of the written-down carrying value will be recognized only when realized or realizable, and no assurance can be given that any such additional recovery will be obtained. Conversely, we have not recorded a liability in respect of any potential adverse outcome, because, taking into account the write-down described above, we do not believe that any further loss is both probable and reasonably estimable at this time. However, if Meteora were to prevail in its claims against us, we may be required to pay damages to Meteora, which could be substantial.
The write-down of our FPA-related prepaid asset resulted in a material non-cash charge to our results of operations for the quarter and reduced our reported equity, and further adjustments could be required in future periods depending on developments in the Meteora litigation.
During the quarter ended June 30, 2026, we recorded a non-cash write-down of our FPA-related prepaid asset to $914,726.53, resulting in a charge of approximately $5.9 million reflected in the Fair value losses in financial instruments carried at fair value in our condensed consolidated statement of operations, and a corresponding reduction in our reported total equity. The write-down was based on our assessment, under U.S. generally accepted accounting principles and in light of the July 9, 2026 USDC NY order and the current procedural posture of the Chancery Court action, of the amount of the FPA-related asset that we consider supportable at this time, and is not a determination of the amount that we believe is legally owed to us by Meteora, which we continue to pursue through the Second Circuit appeal and to defend in the Chancery Court action. The carrying value of the FPA-related asset may require further adjustment in future periods, up to and including reduction to zero, depending on subsequent developments, including the outcome of the Chancery Court’s decision on Meteora’s summary judgment application, the ultimate disposition of the Second Circuit appeal, and any other developments in the Meteora litigation. Because the write-down is non-cash, it did not affect our liquidity in the period recorded; however, the associated reduction in reported earnings and equity, and any further such adjustments, could adversely affect investor perceptions of the Company, the market price and trading volume of our Ordinary Shares and Public Warrants, and our compliance with covenants or other financial requirements under any existing or future financing arrangements.
Publicity concerning the Meteora litigation could adversely affect our reputation and the market price and trading volume of our Ordinary Shares and Public Warrants.
The Meteora litigation, including the USDC NY’s July 9, 2026 order dismissing our claims and our pending appeal of that order, has attracted, and may continue to attract, media and investor attention. Publicity relating to the litigation, including publicity concerning the USDC NY’s characterizations of our pleadings, the interpretation of the FPA and the Subscription Agreement, and our former SPAC counterparties, could adversely affect our reputation, our relationships with commercial counterparties, customers and investors, and the market price and trading volume of our Ordinary Shares and Public Warrants. Adverse publicity concerning the Chancery Court action, or any adverse determination in that action, could have a similar effect. In addition, negative sentiment regarding the litigation may make it more difficult or more costly for us to access the capital markets, negotiate with commercial counterparties, or retain key employees.
The
unaudited financial information of the newly consolidated entities included in this filing is preliminary, and our actual financial condition
and results of operations may differ materially.
The
financial statements of the newly consolidated entities for the period presented are unaudited. The consolidation of acquired or newly
consolidated businesses involves complex and subjective accounting policies and significant estimates, particularly in areas such as
fair value measurements, purchase price allocations, and the identification and elimination of intercompany transactions and balances.
The absence of an independent audit increases the risk that these financial statements could contain material errors or misstatements
that might not be detected on a timely basis, which could adversely affect investor confidence and potentially require restatements in
the future.
Our
newly consolidated joint venture in China exposes us to significant geopolitical, regulatory, and economic risks that could adversely
affect our business, results of operations, and financial condition.
As
a result of our recently consolidated joint venture in China, we are now subject to the economic, political, and regulatory conditions
prevailing in that country. The relationship between the United States and the People’s Republic of China has become increasingly
complex and, at times, adversarial. Ongoing trade tensions, evolving export controls, restrictions on technology transfers, sanctions,
tariffs, and potential limitations on U.S. investment in Chinese entities could materially and adversely affect our ability to operate,
repatriate profits, or maintain supply and customer relationships in China. Actions by either government, including new or expanded restrictions
on cross-border transactions, data flows, or technology licensing, could disrupt our operations or require us to restructure aspects
of our business in China.
In
addition, China’s regional relationships present further geopolitical risks. In particular, increasing tensions between China and
India – a key market and strategic geography for our business – could lead to trade restrictions, border disruptions, or
regulatory actions that may impair our ability to coordinate operations, transfer technology, or manage resources effectively across
jurisdictions. Any deterioration in diplomatic or trade relations among the United States, China and India could also negatively affect
global economic stability and demand for our products and services.
The
Chinese regulatory environment is also characterized by frequent changes and government intervention, including in areas such as data
privacy, foreign investment, and national security reviews. Unanticipated regulatory changes or enforcement actions could adversely affect
our joint venture’s operations, governance, or ownership structure, and could limit our ability to control or derive economic benefit
from the structure.
We
may not receive consistent, complete, or reliable financial and operational information from our joint venture in China, which could
result in material misstatements, impairments, or write-offs of our investment.
Our
recently consolidated joint venture in China presents significant challenges in obtaining timely, accurate, and complete financial information
necessary for U.S. GAAP reporting and internal control purposes. The joint venture operates in a jurisdiction where accounting standards,
internal control practices, and regulatory oversight may differ materially from those in the United States. We rely heavily on local
management for financial reporting, operational metrics, and other information necessary to prepare our consolidated financial statements
and maintain effective internal control over financial reporting. Differences in accounting practices, delays in reporting, or incomplete
disclosures may limit our visibility into the joint venture’s performance and financial condition.
Despite
our oversight efforts, there can be no assurance that we will continue to receive consistent, reliable, or verifiable information from
the joint venture. Delays, inaccuracies, or lack of transparency in financial reporting could impair our ability to prepare consolidated
financial statements in accordance with SEC and PCAOB requirements. If we are unable to obtain sufficient and appropriate information
to support the carrying value of our investment or to ensure compliance with internal control standards, we may be required to record
an impairment charge or a full write-off of our investment in the joint venture.
We
have experienced similar challenges in the past with our joint venture in China, including instances where limited visibility and lack
of reliable financial information led to a full write-off. A recurrence of such issues with our Chinese joint venture could materially
and adversely affect our financial condition, results of operations, and investor confidence in our reporting integrity.
Our
consolidation of the joint venture in China is based on board control rather than majority equity ownership, and changes in governance,
regulation, or local enforcement could cause us to lose control or require deconsolidation.
As
discussed in Note 18. Business Combination to our unaudited condensed consolidated financial statements, we consolidate our joint venture
in China because we currently exercise control through our rights to a majority of the votes of the board of directors, and our ability
to direct the joint venture’s key operating and financial policies. Our equity ownership in the joint venture, however, represents
less than a majority of its outstanding equity interests.
Because
our consolidation is based on governance and contractual rights rather than full equity control, there is no assurance that we will continue
to have the ability to direct the activities that most significantly affect the joint ventures’ economic performance. Any changes
in the joint venture’s governing documents, shareholder arrangements, local corporate law, or government interpretation of control
could limit our decision-making authority or cause us to lose our ability to consolidate the entity under U.S. GAAP.
If
we were required to deconsolidate the joint venture, we would record our remaining interest under the equity method or at fair value,
which could result in a material gain or loss and would significantly reduce our reported revenues, assets, and liabilities. In addition,
loss of control could impair our strategic position in the Chinese market and require us to reassess our local operating model.
Given
the evolving nature of foreign ownership restrictions, corporate governance enforcement, and national security considerations in China,
our continued ability to consolidate the joint venture cannot be assured, and any loss of control could materially and adversely affect
our financial condition, results of operations, and disclosures in future periods.
Management's Discussion & Analysis (MD&A)
New heading “Junior Convertible January 2026 Debentures”
New heading “Underwritten Public Offerings”
Removed heading “Comparison of the Nine Months Ended December 31, 2025 and December 31, 2024”
Removed heading “Recent Developments”
Largest changes
“Upon the occurrence of an Event of Default (as defined in the January Notes), the January Holders will have the right to (i) either require the Company to redeem all or any portion of the January Notes, (ii) or, in the case of a failure to make a required quarterly payment under the January Notes, convert all or any portion of the January Notes at a price equal to the Event of Default Conversion Price (as defined in the January Notes). …”see in full comparison
“Upon the occurrence of an Event of Default (as defined in the January Notes), the January Holders will have the right to (i) either require the Company to redeem all or any portion of the January Notes, (ii) or, in the case of a failure to make a required quarterly payment under the January Notes, convert all or any portion of the January Notes at a price equal to the Event of Default Conversion Price (as defined in the January Notes). …”see in full comparison
“On January 20, 2026, the Company and the Investor entered into an Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Amendment”), which amended certain of the terms of the junior convertible notes issued to the Investor in November 2025 (the “November Notes”) pursuant to the terms of that certain Securities Purchase Agreement dated as of November 20, 2025, as described in the Current Report on Form 8-K filed by the Company on November 20, 2025. …”see in full comparison
“On January 20, 2026, the Company and the Investor entered into an Amendment to Securities Purchase Agreement and Junior Convertible Note (the “Amendment”), which amended certain of the terms of the November Notes. Among other things, the Amendment adds to the November Notes certain cross-default provisions with respect to the January Notes and certain covenants contained in the January Notes.”see in full comparison
“Our U.S. managing general underwriter (“MGU”) subsidiary holds insurance producer licenses in California, Texas, Illinois, and New Jersey, and operates under Coverholder authority granted by Lloyd’s of London, which permits it to bind risks on behalf of one or more Lloyd’s syndicates within the scope of a binding authority agreement. Our U.S. MGU operations are subject to extensive regulation at the U.S. …”see in full comparison
“The January Notes were sold for a gross purchase price of $5,000,000 before fees and other expenses. The January Notes will mature on June 20, 2027 and will bear interest at a rate of 14% per annum (increasing to 18% per annum upon the occurrence and during the continuation of an event of default). $925,000 of the principal amount of the January Notes (less any portion thereof previously converted by the holders), together with accrued but unpaid interest, is payable quarterly, commencing three months after the date of issuance. …”see in full comparison
Full comparison: every changed paragraph (91)
The
following discussion and analysis of the financial condition and results of operations of Roadzen Inc. and its subsidiaries should be
read in conjunction with the “Unaudited Condensed Consolidated Financial Statements of Roadzen Inc. as of and for the three andmonths
nine months ended DecemberJune 31,30, 20252026 and 2024,2025,” together with related notes thereto, included elsewhere in this Form 10-Q (in the
section of this
Form 10-Q entitled “Financial Information”). The following discussion contains forward-looking statements
that involve risks,
uncertainties and assumptions. See the section titled “Cautionary Note Regarding Forward-Looking Statements.” Actual
Actual results and timing of selected events may differ materially from those anticipated in the forward-looking statements as a result
of various
factors, including those set forth or referred to under the section titled “Risk Factors” or elsewhere
in this Form
10-Q.
Roadzen
is a leading Insurtech company on a mission to transform global auto insurance powered by advanced artificial intelligence (“AI”).
At the heart of our mission is our commitment to create transparency, efficiency, and a seamless experience for the millions of end customers
who use our products through our insurer, OEM,original equipment manufacturer (“OEM”), and fleet (such as trucking, delivery, and commercial fleets) partners. We seek to accomplish
this by combining computer vision, telematics and AI with continually updated data sources to provide a more efficient, effective and
informed way of building auto insurance products, assessing damages, processing claims and improving driver safety. Insurers and other
partners of Roadzen across the world use Roadzen’s technology to launch new auto insurance products, manage risk better and resolve
claims faster. These products are built with dynamic underwriting capabilities, Application Programming Interface, or API-led distribution
and real-time claims processing.
Our
operations are global, and our partners consist of market-leading insurance companies, fleets and automotive original equipment manufacturers
(“OEMs”) and carmakers, including AXA, SCOR, Arch, Société Générale, Jaguar Land Rover, Audi,
Mercedes, Volvo and several others. Our subsidiary in the U.K., operates through a specialist Managing General Agent (“MGA”)
based in Coventry, which provides auto insurance, extended warranties, and claims management services to insurers, automotive dealers,
manufacturers, and fleet operators. This MGA leverages its regulatory license to underwrite and service policies locally while utilizing
third-party licenses to deliver solutions globally. It acts as a delegated authority on behalf of insurers, managing policy sales and
claims adjudication via its brokerage platform. Revenue is generated through commissions and administrative fees tied to Gross Written
Premium (“GWP”), with specialty contracts typically structured over five-year terms. Roadzen’s subsidiary in the U.S.,
operates a licensed auto club based in Burlingame, California that specializes in commercial roadside assistance (“RSA”)
and claims management. With a robust network of over 75,000 service providers nationwide, it offers towing, transportation, and first
notice of loss (“FNOL”) services to government fleets, enterprises, insurers, and auto manufacturers. We also operate a California
licensed insurance broker and managing general underwriter based in San Diego, California, after acquiring a majority stake in the quarter
ended December 31, 2025. These capabilities
support our comprehensive suite of mobility and insurance infrastructure services across
North America. Roadzen’s subsidiary in
India operates as a licensed insurance broker providing distribution and servicing of motor
insurance products, including RSA, vehicle
inspection, and claim facilitation. We also operate a workshop management platform, digitizing
end-to-end auto repair across a network of more than 1,350 verified garages and car repair workshops. Our India operations also serve
as the Company’s global technology headquarters, where our
product, engineering, and AI teams develop and scale the core platforms
that power our insurance and mobility services worldwide. This
integrated approach allows us to drive innovation and operational efficiency
across all markets we serve.
In the People’s Republic of China, we operate a data analytics and AI-enabled software company serving the insurance and mobility value chain in the Greater China market.
Our
mission is to build the leading company at the intersection of artificial intelligence (“AI”), insurance and mobility. To
further our mission,
we have built a pioneering lab focused on fundamental and applied AI research. We work on core research areas in
computer vision, generative
AI, and traditional machine learning to develop product experiences that improve the safety, convenience,
and protection of millions
of drivers across the world. Roadzen is a founding member of the AI Alliance fostering safe, responsible,
and open-sourceopen source development
alongside industry leaders such as Meta, IBM, Hugging Face, Stability AI, AMD, Service Now, and others. Our
approach to build precision
AI models in insurance and mobility has won several industry accolades. Roadzen achieved significant industry
recognition for its advancements
in AI and technology during the lastfiscal severalyear years.ended March 31, 2026. Honors included ‘Breakthrough in Computer Vision’ (FE AICONIC Summit & Awards
2026), InsurTech Solution of the Year (Fintech Breakthrough Awards 2026), ‘Best Insurtech’ (Bharat Fintech Summit Awards
2026), ‘Best AI in Deep Tech’
at the AI Awards Summit 2025 by Entrepreneur India and secured a spot on the Fintech40 Index
by L’Observatoire de la Fintech. It
was named the ‘World’s Top InsurTech’ by CNBC in 2024, ‘Most Innovative
Use of AI’ by Financial Express
at the FE Futech Awards 2024 and won the Gold Stevie Award for its xClaimClaims insurance solution at
the International Business Awards 2024.
Additional recognitions included ‘Excellence in InsurTech’ by the India FinTech Forum
(IFTA 2024), ‘Best Use of AI
in Insurance’ at the Global AI Summit & Awards (GAISA 2024), and ‘Best Product and
Business Team’ at the World
Auto Forum 2024. Roadzen also won ‘Best Use of Technology’ at the Entrepreneur Awards 2024
and ‘Most Innovative Company’
at the World Finance Innovation Awards 2024.
Roadzen’s
IaaS Platform accounted for approximately 56% and 54%55% of revenues for the three and nine months ended DecemberJune 31,30, 2025.2026.
Roadzen
acts as an insurance broker utilizing its technology to sell insurance through our embedded and B2B2C distribution model. The policies
are sold by insurance intermediaries such as agents and through captive distributors such as dealerships, fleets and used car platforms.
Our B2B2C channel partners choose us for a variety of reasons - for the ease of integrating our technology through APIs into their ecosystem,
for a seamless, fully digital customer experience from obtaining a policy to submitting a claim, and for integrations with a large number
of insurance companies who sell their policies through our platform to give theirthe users a handful of policy options, and our ability to
to deliver multiple relevant products such as auto insurance, commercial and fleet insurance, extended warranty, guaranteed asset protection,
and other automotive related insurance products. Lastly, we are able to provide a superior customer experience for the end user by bundling
telematics for road safety, RSA and claims management to the customer - an experience that we believe is unrivaled by other traditional
brokers. Roadzen’s revenues are based on commissions and other fees that are paid by our insurance carriers as a percentage of
the GWP underwritten for each policy.
Roadzen’s
brokerage solutions accounted for approximately 44%
and 46%45% of revenues for the three and nine months ended DecemberJune 31,30, 2025.2026.
We
continue to develop and invest in our technology platform to drive scalability and build innovative products. We believe our significant
proprietary investments into our data pipelines, training, model development and our core technology platform are key advantages that
allow us to stay ahead of the competition, support our growth into global markets and improve operating margins.
Since
January 1, 2023 we began tracking customer segmentation for Roadzen, described as such: enterprise clients that include insurers, automakers
and large fleets (above 100 vehicles), and SMB clients, which include agents, brokers, small dealerships, and small fleets (under 100
vehicles). As of DecemberJune 31,30, 2025,2026, we had 61 insurance customer agreements (including carriers, self-insureds and other entities
processing processing
insurance claims), 8796 automotive customer agreements, and approximately 4,1004,240 agents and fleet customers agreements.
We
generate a majority of our revenues through commissions and fees which are a reflection of the total insurance policy premium. Roadzen
derived 44%45% of revenue from its Brokerage Solutions and 56%55% from its IaaS Platform for the three
months ended DecemberJune 31,30, 2025.2026. A softening
of the insurance market characterized by a period of declining premium rates due to competition
or regulation could negatively impact
our financial results.
Our
subsidiary in the U.K. is licensed as a Managing General Agent (“MGA”),MGA, under which we are subject to stringent oversight
by the Financial Conduct Authority (“FCA”). Our operations must align
with FCA regulations that are specifically tailored
to govern the conduct and obligations of MGAs, which act as an intermediary between
insurers and clients, with delegated authority to
underwrite and process claims on behalf of insurers. Our adherence to these regulations
encompasses a variety of compliance obligations,
including but not limited to, ensuring that underwriting decisions are made with the
requisite skill and care, maintaining accurate and
secure records of insurance contracts, managing potential conflicts of interest, and
safeguarding client funds. The FCA also imposes
comprehensive conduct rules and solvency requirements that require us to act with due
care in the interests of policyholders.
The
FCA has the authority to suspend the sale of any insurance product sold within the U.K. and for which it has oversight, if it does not
believe a firm or a product is protecting the interests of U.K. consumers. EffectiveFor example, in February 2024, the FCA paused all sales of
the Guaranteed
Asset Protection (“GAP”) product, a key contributor to our operations in the U.K., directing all insurers,
including our
insurance partner, to temporarily cease selling the GAP product. The regulator mandated insurers to make a resubmission,
or new GAP proposal,
outlining product features, coverages and pricing for approval by the FCA before sales of the GAP product could
be resumed. Although our insurance partner, which is obligated to adhere to FCA guidelines, eventually received approval to sell GAP
products, the resubmission and approval process had a significant impact on our revenue, financial performance, and overall profitability.
Although
our insurance partner, which is obligated to adhere to FCA guidelines, received approval to sell GAP products, the resubmission and approval
process had a significant impact on our revenue, financial performance, and overall profitability.
NationalOur
Automobileauto Club, ourclub subsidiary in the U.S. is licensed as an auto club in California, which exposes Roadzen to a distinct set of risks
due to the stringent regulatory
landscape enforced by the California Department of Insurance. EliteCover, our other majority-owned subsidiary
in the U.S. is licensed as a commercial auto insurance broker and managing general underwriterInsurance (MGU“CDI”) operating across multiple U.S. states
including California, Texas, Illinois, and New Jersey, as well as in the U.K. through Lloyd’s of London.. Compliance with these regulations
is paramount, as
they govern a wide spectrum of our activities, including membership services, claims management, and financial integrity.
Our U.S. managing general underwriter (“MGU”) subsidiary holds insurance producer licenses in California, Texas, Illinois, and New Jersey, and operates under Coverholder authority granted by Lloyd’s of London, which permits it to bind risks on behalf of one or more Lloyd’s syndicates within the scope of a binding authority agreement. Our U.S. MGU operations are subject to extensive regulation at the U.S. state level, including licensing, financial responsibility, fiduciary handling of premium and claim funds, recordkeeping, reporting, market conduct, producer compensation, and, in certain states, specific managing general agent statutes modeled on the National Association of Insurance Commissioners’ Managing General Agents Act. Our Coverholder authority is governed by the binding authority agreements with our Lloyd’s carriers and by the underwriting, audit, conduct, complaint-handling, sanctions, and reporting standards established by Lloyd’s and overseen in the United Kingdom by the Prudential Regulation Authority and the FCA. Our financial performance depends on our ability to maintain these licenses and authorities in good standing, to operate within delegated underwriting authority and aggregate limits set by our carriers, and to comply with applicable state and Lloyd’s requirements. Changes in state insurance laws or regulations, modifications to Lloyd’s Coverholder or delegated authority standards, loss or suspension of a license or Coverholder authority, reductions or non-renewals of delegated underwriting authority by our carrier partners, adverse findings from regulatory examinations or carrier audits, or changes in commission structures or premium volumes in the lines we administer could each have a material effect on the revenue, operating results, and cash flows. We also incur ongoing compliance costs to support our multi-jurisdictional licensing footprint, which we expect to increase as we expand into additional states and add carrier relationships.
Revenue
We
provide access to our IaaS solutions through contractual agreements with our customers, whereby the customer receives one or a bundle
of our solutions, which can include inspection, claims management, RSA, and/or telematics offerings. The average contract length for
our IaaS customers is approximately three years. Our clients pay us on a fixed fee per-incident or per-vehicle. Our brokerage revenues
are based on commissions and fees that we receive from our insurance partners for selling their policies to customers as well as providing
other client services such as claims management. Our commissions and fees are calculated as a percentage of athe policy’sGWP GWP.underwritten for
each policy.
Comparison
of the Three Months Ended DecemberJune 31,30, 20252026 and DecemberJune 31,30, 20242025
Revenue
Comparison
of the Nine Months Ended December 31, 2025 and December 31, 2024
Revenue
increased by $2.3 million, representing a 19% increase for the three months ending December 31, 2025, compared to the same period the
prior year. This increase was primarily due to the consolidation of our Variable Interest Entity (“VIE”) in China, Daokang
(Beijing) Data Science Company Limited and addition of new clients in India.
Commission
and Commission and Distribution Income decreased by $0.9 million, or 12%, compared to the same period in the previous year.
Revenue
from the Insurance as a Service (IaaS) platform increased by $3.2 million, or 65%, for the three months ending December 31, 2025 primarily
due to the consolidation of our VIE in China, which contributed $2.1 million, and expansion in existing business in India.
As
of December 31, 2025, the Company maintained 61 insurance customer agreements and 87 automotive customer agreements, as well as approximately
4,100 agents and fleet customer agreements.
Revenue
increased by $6.0 million, or 18%, for the nine months ending December 31, 2025, compared to the same period the prior year. This increase
was primarily due to the consolidation of our VIE in China, Daokang, and expansion of our distribution network.
Commission
and Commission and Distribution Income increased by $1.7$1.6 million, or 10%,28%, compared to the same period in the previous year. This growth increase
was supported
primarily driven by strategic marketingexpansion effortsinitiatives, andincluding the expansionacquisition of ourElite distributionCover network,Insurance allowingin usthe U.S., which contributed
approximately $1.1 million in revenue, in addition to access$0.5 newmillion customerof segmentsorganic andgrowth enhance
productin penetration within existing markets.India.
Revenue from the Insurance-as-a-Service (IaaS) platform increased by approximately $3.7 million, or 72.0% compared to the prior year period. The increase was primarily driven by the consolidation of VehicleCare, which contributed approximately $2.3 million and the consolidation of our VIE in China, which contributed approximately $0.6 million in revenue during the period. The remaining increase was attributable to the continued expansion of our existing business operations, including growth from our current customer base and increased adoption of our IaaS platform offerings.
As of June 30, 2026, the Company maintained 61 insurance customer agreements and 96 automotive customer agreements, as well as approximately 4,240 agents and fleet customer agreements.
Revenue
from the Insurance as a Service (IaaS) platform increased by $4.3 million, or 26%, for the nine months ending December 31, 2025 primarily
due to the consolidation of our VIE in China and addition of new client in India.
Cost
of services increased by $0.9$2.5 million, or 22%,54.9%, for the three months endingended DecemberJune 31,30, 20252026, compared to the same
period periodin the prior year.
This The increase was primarily driven by the consolidationexpansion of ourthe VIECompany’s inInsurance-as-a-Service Chinaoperations
following recent business combinations and increasedplatform IaaSintegration revenue.activities, together with higher transaction volumes and continued organic
growth across the Company’s existing operations.
Cost
of services increased by $0.8 million, or 5%, for the nine months ending December 31, 2025 compared to the same period the prior year,
as cost of service directly correlates to revenue, the increase is primarily driven by the increase in revenue.
Research
and development expenses increased by $0.04$0.3 million, or 18%,414.0%, for the three months ended DecemberJune 31,30, 2025,2026, compared to the same period
in the prior year. The increase was primarily attributable to a decrease in capitalization during the period compared to the same period
the prior year.
Research
and development expenses decreased by $3.0 million, or 85%, for the nine months ended December 31, 2025, compared to the same period
in the prior year. The reduction was primarily attributable to a $2.6 million decline in non-cash compensation expense associated with
RSU grants, a $0.2 million increase in capitalization relative to the prior period and $0.2 million decrease in costs related to technology
personnel and consulting services.
Sales
and marketing expense decreased by $0.3 million, or 4%, for the three months ended December 31, 2025 compared to the same period the
prior year. This reduction primarily reflects the company’s ongoing cost optimization initiatives.
Sales
and marketing expense decreasedincreased by $1.7$1.1 million, or 8%,17.5%, for the ninethree months ended DecemberJune 31,30, 20252026 compared to the same period the prior
year. The decreaseincrease was primarily attributabledriven by the acquisition of Elite Cover Insurance in the U.S., which contributed approximately $0.8 million, and
remaining was due to a $3.6 million decline in non-cash compensation expense related to RSU grants, partially
offset by $1.9 million rise in expenses due totowards enhanced marketing efforts related to increasingthe increase in distribution income during previous quarter.
income.
General
and administrative expenses increased by $0.8 million, or 22%, for the three months ended December 31, 2025, compared to the same period
in the prior year. This increase was primarily driven by the consolidation of our VIE in China and EliteCover.
General
and administrative expenses declineddecreased by $39$0.2 million, or 80%,4.6%, for the ninethree months ended DecemberJune 31,30, 2025, 2026,
compared to the same period
in the prior year. ThisThe decrease was primarily drivenattributable byto the reversal of a $40.7provision millionfor reductiondoubtful indebts
of non-cashapproximately RSU$2.8 expenses,million, partially offset by an increase
of $1.3approximately $1.0 million in the provision for expected credit losses.
General and $0.2administrative expenses also reflected approximately $0.6 million of incremental costs associated towith the consolidation of
recently acquired businesses, as well as approximately $0.8 million of non-cash legal and professional expenses related to acquisition
and integration activities incurred during the VIE in China and EliteCover respectively. The remaining variance
attributable to the routine operating activities.period.
Depreciation
and amortization increased by $0.01$0.6 million, or 4%,483.6%, for the three months ended DecemberJune 31,30, 2025,2026, compared to the same period the prior
year.
Depreciation
and amortization increased by $0.2 million, or 22%, for the nine months ended December 31, 2025, compared to the same period the prior
year.
Interest
expense increased $2.1$1.9 million, or 194%,203.3%, for the three months ended DecemberJune 31,30, 20252026 compared to the same period the prior year primarily
due to an increase in borrowings from banks and other parties.
Interest
expense increased $2.8 million, or 112%, for the nine months ended December 31, 2025 compared to the same period the prior year primarily
due to an increase in borrowings from banks and other parties.
Loss
on fair valuation changes increased by $6.9 million, or 400%, for the three months ended December 31, 2025 compared to the same period
the prior year due to the fair market valuation of our convertible promissory notes, share warrants and the consolidation of Daokang
and EliteCover. The Company has not yet conducted a Purchase Price Allocation (“PPA”) valuation of Daokang, which may result
in a change of the fair valuation of Daokang, currently recorded at $0.9 million.
Loss
on fair valuation changes decreased
increased by $11.9$6.7 million, or 72%,1309.6%, for the ninethree months ended DecemberJune 31,30, 20252026 compared to the same period
the prior year due to the non-cash
write-down of approximately $5.9 million with respect to the Forward Purchase Agreement-related prepaid asset, and the fair market valuation
of our convertible promissory notes,notes and share warrants and the consolidation of Daokang
and EliteCover. The Company has not conducted a PPA valuation of Daokang, which may result in a change of the fair valuation of Daokang,
currently recorded at $0.9 million.warrants.
Other
income (expense), net,Income increased by$1.9 $1.2 million, or 2126%,million for the three months ended DecemberJune 31,30, 2025,2026 compared to the same period
in the prior year. The increase This
was primarily driven by a higherthe write-back of certain liabilities.liabilities of $1.8 million.
Other
income (expense), net, decreased by $0.7 million, or 22%, for the nine months ended December 31, 2025, compared to the same period in
the prior year. The decrease was primarily driven by a lower write-back of certain liabilities related to payables inherited from the
Business Combination of $2.4 million during the current period, compared to $3.8 million in the prior-year period. The prior year period
was also partially offset by $0.7 million in write-offs of customer contracts.
The
following table reconciles our net loss reported in accordance with GAAP to Adjusted EBITDA for the three months ended DecemberJune 31,30, 20252026
and DecemberJune 31,30, 20242025:
The
following table reconciles our net loss reported in accordance with GAAP to Adjusted EBITDA for the six months ended December 31, 2025
and December 31, 2024:
Since
our incorporation, we have financed our growth through a blend of equity, convertible instruments, debt (including working capital lines),
and customer payments. As of DecemberJune 31,30, 2025,2026, we have raised an aggregate of $61.5$77.7 million, net of issuance costs, through the issuance
of Ordinary Shares, convertible instruments and preferred stock of Roadzen (DE). Our accumulated deficit stood at $240.2$255.9 million as of
DecemberJune 30, 2026, compared to $247.5 million as of March 31, 2025 up from $224.3 million from the previous year.2026. These accumulated deficits stemare fromthe result of substantial operating losses,
which resulting
frominclude expenses related to fair valuation adjustments, the vesting of derivative instruments including RSUs, the impairment of investment and intangible assets, and
transaction costs
related to the Business Combination. These losses arehave been detailed in the table below. We anticipate that we will
continue to experience
operating losses and generate negative cash flows from operations inover thean nearextended futureperiod due to the planned investments
in our business.
Consequently, we maywill need to secure additional capital resources to support the execution of our strategic initiatives
for growing our
business in the coming years.
Our
future capital requirements will depend on many factors, including, but not limited to, our growth, our ability to attract and retain
customers, the continued market acceptance of our solutions, the timing and extent of spending to support our efforts to develop our
platform, and the expansion of sales and marketing activities. Further, we may in the future enter into arrangements to acquire or invest
in businesses, products, services and technologies. We maywill be required to seek additional equity or debt financing. In the event that
additional financing is required, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional
capital when desired, our business, financial condition and results of operations could be adversely affected.
Our
largest sources of cash provided by operations are increases in accounts payablepayables and payments received from our customers. Our primary
uses of cash from operating activities include employee-related expenses, sales and marketing expenses, third-party cloud infrastructure
expenses and other overhead costs.
For
the ninethree months ended DecemberJune 31,30, 2025,2026, net cash used in operating activities
was $16.4$5.5 million, an increase of $2.0$2.6 million compared
to $14.4$2.9 million for the same period the prior year. This increase primarily reflects a combination of lower net losses and changes in
working capital during the current period.
The
cash outflow in the nine months ended December 31, 2025 was primarily driven by a net loss of $15.2$9.8 million, net
cash outflow of $6.1
$1.3 million resulting from changes in operating assets and liabilities, including decreased payables and higher receivables
and non-cash
adjustments totaling $4.9$5.4 million.
Cash
used infrom investing activities
was of $0.7$1.4 million for the ninethree months ended DecemberJune 31,30, 2025,2026, consistedconsisting of $0.8$0.4 million of capital
expenditure relatedfor tonew capitalizationoffice of tangible facilities
and intangible assets and $0.1$0.9 million receivedpaid fromfor business acquired in the investmentsprior in mutual
funds (held for sale).year.
We have generated negative cash flows from operations since our inception and have supplemented working capital through net proceeds from the issuance of Ordinary Shares as well as the issuance of debt. Cash provided by financing activities was $6.3 million for the three months ended June 30, 2026, which consisted primarily of $7.4 million from the issuance of Ordinary Shares, partially offset by $1.2 million in repayments of borrowings.
Cash
provided by financing activities of $15.9 million for the nine months ended December 31, 2025, consisted primarily of $6.5 million
from the issuance of Ordinary Shares by the Company and $6.5 million from issuance of equity shares of subsidiary company and $2.9
million from proceeds of borrowings.
On
January 30, 2024, the Company and the Seller entered into an amendment to the Forward Purchase Agreement (the “Amendment”).
The Amendment amends the section of the Forward Purchase Agreement regarding a Prepayment Shortfall by providing that the Company has
the option, at its sole discretion, at any time up to 45 days prior to the Valuation Date, to request up to $5 million in Prepayment
Shortfall via ten separate written requests to Seller in the amount of $500,000 each (each, an “Additional Shortfall Request”),
provided that at the time of any Additional Shortfall Request (i) Seller has recovered 117% of the prior Additional Shortfall Request,
if any, via Shortfall Sales and (ii) the VWAP Price over the ten trading days prior to such Additional Shortfall Request multiplied by
the then current Number of Shares less Shortfall Sale Shares held by Seller is at least seven times greater than such Additional Shortfall
Request. In addition, the Amendment amends the section of the Forward Purchase Agreement regarding Prepayment Shortfall Consideration
by eliminating the 180-day period following a Trade Date before Seller may commence selling Recycled Shares and by permitting such sales
without payment by Seller of any Early Termination Obligation until such time as the proceeds from such sales equal 117% (instead of
100% as originally provided in the Forward Purchase Agreement) of the Prepayment Shortfall. During the yearperiod ended MarchJune 31,30, 2025,2026, anthe
Company did not receive any additional $1 million was receivedpayments from the Seller, bringing theSeller; total cash receipts toremain at $4.8 million.
The
following table summarizes our contractual obligations as of DecemberJune 31,30, 20252026:
One of our material subsidiaries issued Secured, Non-Convertible Debentures with NP1 Capital Trust with an aggregate principal amount of $3.7 million during the fiscal year ended March 31, 2023 with varying maturity dates between January 2024 and July 2024 and interest rates ranging from 19.25% to 20.00% per year. On September 30, 2024 the Company entered into an amendment agreement restructuring the principal repayments and extending the maturity date to March 31, 2025. The Company did not honor the repayment of the above debentures as of the amended date, and obtained an extension from the lender up to November 30, 2025. In October 2025, the Company entered into negotiations with the lender to settle all principal and accrued interest, including late payment charges, partly in cash and partly in equity of the Company’s Indian subsidiary , and extending maturity to August 15, 2026. As of June 30, 2026, the outstanding balance was $0.3 million.
On June 30, 2023, Roadzen entered into a Senior Secured Note Purchase Agreement (the “Note Purchase Agreement”) with Mizuho Securities USA LLC (“Mizuho”), as administrative agent and collateral agent, and as a purchaser, pursuant to which Mizuho purchased an aggregate principal amount of $7,500,000 of senior secured notes (the “Mizuho Notes”). The Mizuho Notes bear interest at a rate of 15.0% per annum, which will automatically increase by 5% if we fail to prepay the Mizuho Notes upon the occurrence of certain mandatory prepayment events as set forth in the Note Purchase Agreement; however, we may prepay all or any portion of the Mizuho Notes prior to maturity at our option without penalty.
RDZN insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding RDZN (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 482,850 | $705.0K | 0.0% | New position |
| Millennium Management (Israel Englander) | 2026-06-30 | 321,438 | $385.7K | — | Sold out |
| Renaissance Technologies | 2026-06-30 | 41,441 | $60.5K | 0.0% | New position |
| D. E. Shaw & Co. | 2026-06-30 | 175,000 | $33.2K | 0.0% | No change |